JN Medsys receives CE-IVD mark for its ProTect COVID-19 RT-qPCR kit 2.0 test
JN Medsys has received the CE mark for its ProTect COVID-19 RT-qPCR kit 2.0. The test is used for the detection of SARS-CoV-2 virus from nasopharyngeal swabs and is able to deliver results within 2 hours. Furthermore, this kit detects for multiple targets all within one reaction, resulting in higher throughput to meet increasing demands for SARS-CoV-2 detection.
The test has also received Singapore Health Sciences Authority provisional authorisation. The Singapore-based company has already began exporting the tests for SARS-CoV-2 detection.